S
SilkTech Biopharmaceuticals
0 followers
SilkTech Biopharmaceuticals develops silk-based anti-inflammatory therapies. Their lead indication is Dry Eye Disease, an inflammatory-based chronic condition.
Org chart
Brian Lawrence
Chief Executive Officer
Collapse
David Infanger
VP, Research & Development
Mark Payne
CFO
Eric D. Donnenfeld
Founding Partner Of Ophthalmic Consultants Of Connecticut
Richard L. Lindstrom
Founding Partner Of Minnesota Eye Consultants
Edward Holland
Director Of Cornea Services At Cincinnati Eye Institute
Board & advisors
Brian Levy
Executive Chairman
Alex Soltani
Board Member
Bill Mower
Board Member
Emmett Cunningham
Board Member
Paul M. Karpecki
Board Member
Richard L. Lindstrom
Advisor
Edward Holland
Advisor
Tim Comstock
Advisor
Debra Schaumberg
Advisor
Gary D. Novack
Advisor
Eric Donnenfeld
Advisor